Female sexual dysfunction: a focus on flibanserin
نویسندگان
چکیده
منابع مشابه
Female sexual dysfunction: a focus on flibanserin
Flibanserin is the first US Food and Drug Administration (FDA)-approved option for sexual dysfunction, specifically low sexual desire. Until recently, there were no FDA-approved medication options to assist the ~40% of women affected by female sexual dysfunction (FSD). Often, patients report feeling uncomfortable discussing sexual health, identifying a strong need for health care professionals ...
متن کاملNew developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
The objective of the authors is to highlight the historical complexities for the diagnosis and treatment of hypoactive sexual desire disorder (HSDD) with a focus on Flibanserin. A systematic review of the medical literature published in PubMed using the search terms HSDD and Flibanserin was conducted. Each author reviewed the results of the systematic review for articles to include in this stud...
متن کاملFemale sexual dysfunction
Graziottin A 2005a Sexual pain disorders in adolescents. In: Genazzani A (ed) Proceedings of the 12th World Congress of Human Reproduction, International Academy of Human Reproduction, Venice, 10–13. CIC Edizioni Internazionali, Roma, p 434–449 Graziottin A 2006 Why deny dyspareunia its sexual meaning? Archives of Sexual Behaviour 34(1):32–34 Graziottin A 2006 Breast cancer and its effects on w...
متن کاملMelissa officinalis effect on female sexual dysfunction: a double blind, randomized clinical trial
Background and objectives: Female sexual dysfunction is a very common health problem that affects 25-65% of women. Melissa officinalis or lemon balm (Lamiaceae) has been reported in folk medicine for treatment of nervous debility, so this study was designed to evaluate the efficacy of M. officinalis to improve female libido. Methods: Eighty ni...
متن کاملEpidemiology of female sexual dysfunction.
OBJECTIVE To review the epidemiology and co-morbidity of female sexual dysfunction. METHOD The prevalence of each sexual dysfunction was evaluated by undertaking a Medline (1969-2008) literature review. The effect of concomitant diseases and drug therapies was also studied. RESULTS Describing the epidemiology of female sexual dysfunction is difficult due to the fact that it has not been stu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Women's Health
سال: 2017
ISSN: 1179-1411
DOI: 10.2147/ijwh.s83747